Quest Diagnostics (DGX) Tops Q3 EPS by 10c; updates guidance
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $193.58 -0.73%
Revenue Growth %: +8.0%
Financial Fact:
Net revenues: 1.89B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +8.0%
Financial Fact:
Net revenues: 1.89B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q3 EPS of $2.60, $0.10 better than the analyst estimate of $2.50. Revenue for the quarter came in at $2.82 billion versus the consensus estimate of $2.73 billion.
GUIDANCE:
Quest Diagnostics sees FY2025 EPS of $9.76-$8.84, versus the consensus of $9.75. Quest Diagnostics sees FY2025 revenue of $10.96-11 billion, versus the consensus of $10.869 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- KeyCorp (KEY) files for 158.72M share offering by selling stockholders
- Eledon Pharamceuticals (ELDN) PT Raised to $7 at Leerink
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
